SciClone Pharma (SCLN) Tops Q1 EPS by 16c
Get Alerts SCLN Hot Sheet
Financial Fact:
Other (expense) income, net: 451K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
SciClone Pharma (NASDAQ: SCLN) reported Q1 EPS of $0.19, $0.16 better than the analyst estimate of $0.03. Revenue for the quarter came in at $33.6 million versus the consensus estimate of $34 million.
As of March 31, 2015, cash, cash equivalents and short-term investments totaled $96.1 million, compared to $86.3 million as of December 31, 2014. SciClone has a share repurchase program under which its Board of Directors has authorized $80.5 million, of which approximately $68 million had been utilized through March 31, 2015.
For earnings history and earnings-related data on SciClone Pharma (SCLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- OSI Systems (OSIS) Tops Q3 EPS by 6c
- Southern Copper Corp. (SCCO) Tops Q1 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!